Rachel King - May 1, 2024 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Role
Director
Signature
/s/ Brian F. Leaf, Attorney-in-Fact
Stock symbol
GLYC
Transactions as of
May 1, 2024
Transactions value $
$0
Form type
4
Date filed
5/1/2024, 04:27 PM
Previous filing
Jan 2, 2024
Next filing
Jun 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLYC Stock Option (right to buy) Award $0 +40K $0.00 40K May 1, 2024 Common Stock 40K $1.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest on May 1, 2025, subject to the reporting person's continuous service as of such vesting date.